Group One Trading
IRWD icon

Group One Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

Group One Trading’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,403
Closed -$3.34K – 7955
2024
Q4 		$6.21K Buy
1,403
+343
+32% +$1.39K ﹤0.01% 6321
2024
Q3 		$4.37K Buy
+1,060
New +$5.7K ﹤0.01% 5931
2023
Q3 		– Sell
-75
Closed -$735 – 7951
2023
Q2 		$798 Buy
+75
New +$806 ﹤0.01% 7303
2022
Q2 		– Sell
-663
Closed -$7.81K – 8140
2022
Q1 		$8K Sell
663
-19,056
-97% -$218K ﹤0.01% 7248
2021
Q4 		$230K Sell
19,719
-587
-3% -$7.2K ﹤0.01% 4947
2021
Q3 		$265K Buy
20,306
+3,777
+23% +$48.8K ﹤0.01% 4886
2021
Q2 		$213K Buy
16,529
+7,063
+75% +$80.8K ﹤0.01% 5187
2021
Q1 		$106K Buy
9,466
+6,574
+227% +$69.4K ﹤0.01% 5605
2020
Q4 		$33K Sell
2,892
-14,697
-84% -$161K ﹤0.01% 5246
2020
Q3 		$158K Buy
17,589
+7,523
+75% +$74.8K ﹤0.01% 3845
2020
Q2 		$104K Buy
10,066
+9,468
+1,583% +$96.9K ﹤0.01% 3877
2020
Q1 		$6K Buy
+598
New +$7.03K ﹤0.01% 4727
2019
Q3 		– Sell
-110
Closed -$1.07K – 5333
2019
Q2 		$1K Sell
110
-2,358
-96% -$26.4K ﹤0.01% 4817
2019
Q1 		$28K Sell
2,468
-18,044
-88% -$202K ﹤0.01% 3878
2018
Q4 		$178K Buy
+20,512
New +$235K ﹤0.01% 2776
2018
Q2 		– Sell
-4,413
Closed -$65.3K – 5277
2018
Q1 		$57K Buy
4,413
+4,123
+1,422% +$51.4K ﹤0.01% 3593
2017
Q4 		$4K Sell
290
-7,146
-96% -$93.3K ﹤0.01% 4609
2017
Q3 		$98K Buy
7,436
+3,638
+96% +$50.1K ﹤0.01% 3261
2017
Q2 		$60K Buy
+3,798
New +$55.2K ﹤0.01% 3409
2015
Q4 		– Sell
-70,682
Closed -$683K – 4896
2015
Q3 		$617K Buy
70,682
+37,152
+111% +$347K 0.01% 1609
2015
Q2 		$339K Buy
+33,530
New +$390K ﹤0.01% 2123
2014
Q4 		– Sell
-6,204
Closed -$71K – 5074
2014
Q3 		$67K Sell
6,204
-632
-9% -$7.24K ﹤0.01% 3326
2014
Q2 		$88K Sell
6,836
-70,240
-91% -$764K ﹤0.01% 3112
2014
Q1 		$795K Buy
77,076
+46,093
+149% +$518K 0.01% 1263
2013
Q4 		$301K Buy
+30,983
New +$278K ﹤0.01% 2069
2013
Q3 		– Sell
-2,647
Closed -$26K – 5398
2013
Q2 		$22K Buy
+2,647
New +$32.1K ﹤0.01% 4018

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's IRWD Position: Q1 2025 in Review

Group One Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 1,403 shares — an estimated $3.34K sold.

Group One Trading first reported a position in IRWD in Q2 2013 and held it in 26 quarters. The position peaked at $795K in Q1 2014. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Group One Trading reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 1,403 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $3.34K.
  • Group One Trading first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Group One Trading's Ironwood Pharmaceuticals position peaked at $795K in Q1 2014.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.